Sophia Genetics reaffirm 72 million dollars – $ 76 million 2025 revenue guidelines, as Astrazneyca Deal Outlook Biopharma pays

Sophia Genetics reaffirm 72 million dollars – $ 76 million 2025 revenue guidelines, as Astrazneyca Deal Outlook Biopharma pays



[og_img]

Source link